BMEYE's haemodynamic monitors:
This article was originally published in Clinica
Dutch firm BMEYE has CE-marked for sale in Europe its Nexfin line of noninvasive haemodynamic monitors. The products allow doctors to accurately and easily monitor continuous blood pressure and cardiac output. They use an easy-to-apply finger sensor to produce data displayed on an intuitive touch-screen, said the Amsterdam-based firm.
You may also be interested in...
After a 12-month period that has seen Stada make significant investments in generics, biosimilars and consumer healthcare, CEO Peter Goldschmidt tells Generics Bulletin that the firm does not intend to stop there, as it pursues both organic and inorganic growth opportunities.
Samsung Bioepis is the latest company to stare down a lawsuit from Genentech over Avastin patents in the US. The Korean firm is aiming to be amongst the early biosimilar movers, after the market formed a year ago.
The US FDA has given the go-ahead for marketing of ViiV healthcare’s novel HIV drug just as the EMA removes the accelerated assessment status from its application there.